Moneycontrol PRO
HomeNewsDrreddyslaboratories

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Citi cuts Sensex target on FY19 earnings downgrade risks; bets on 20 stocks with up to 60% return

    Global brokerage house Citi expects double digit growth for current financial year (FY19) but with some downgrade risks.

  • Buy, Sell, Hold: 8 stocks on anlaysts' radar on March 26, 2018

    Nomura has initiated coverage with Buy call on Tejas Networks and set a target price at Rs 430 per share.

  • Bull's Eye: Sell Dr Reddy's Lab, Raymond, Capital First; buy Marico, Titan, Bata

    Manav Chopra of Indiabulls Ventures advises buying Titan Company with a target of Rs 925.

  • Buy, Sell, Hold: 5 stocks are on analysts’ radar on March 21, 2018

    GSPL, Cipla and Bharti Airtel, among others, are being tracked by investors on Wednesday.

  • Buy or sell: Stock trading ideas by Ashwani Gujral, Mitessh Thakkar for March 20

    Mitessh Thakkar of miteshthacker.com advises selling Arvind with a target of Rs 372.

  • Nifty may face hurdle at 10,400; top 5 stocks with up to 5% return potential in short term

    "The index has formed 'Spinning Top' candlestick pattern indicating lack of momentum on either side. Now Nifty has to close above 10,250 marks for further upside. The level 10,400 will work as immediate hurdle zone and support is seen around 10,130 mark," says Rajesh Agarwal of AUM Capital.

  • Buy, Sell, Hold: Analysts are tracking 4 stocks and 2 sectors on March 5

    Credit Suisse has upgraded Aurobindo to Outperform from Neutral rating with a target price at Rs 750 per share as the stock is attractive for low valuations at 13x FY19 EPS.

  • Buy Sun Pharma, says Rajat Bose

    Rajat Bose of rajatkbose.com advises buying Sun Pharma.

  • Stay with Dr Reddy's Laboratories, says Vijay Chopra

    According to Vijay Chopra of enochventures.com, one may stay with Dr Reddy's Laboratories.

  • Buy Ashok Leyland, Dr Reddy's Labs, Bharat Forge; sell Axis Bank: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com recommends buying Ashok Leyland, Dr Reddy's Labs and Bharat Forge and advises selling Axis Bank.

  • Bull's Eye: Buy India Cements, Dr Reddy's Lab, Alembic, Century Ply, Uflex, Jain Irrigation

    Gaurav Ratnaparkhi of Sharekhan advises buying Dr Reddy's Lab with a target of Rs 2283.

  • Buy Apollo Hospitals, Escorts, Kotak Mahindra Bank; avoid Dr Reddy's Labs: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Apollo Hospitals, Escorts and Kotak Mahindra Bank and can avoid Dr Reddy's Labs.

  • Short Nifty if it slips below 10300; 3 stocks which could give up to 7% return

    It would be advisable to initiate fresh shorts only below 10300 in the Nifty. Resistance for the same would remain in the range of 10600-10640.

  • Nifty likely to find support at 10,276; 3 stocks which could give up to 17% return

    Looking at the weekly chart formed last week, Nifty formed a Bearish Engulfing pattern and the impact of the said pattern was clearly seen in this week.

  • Sell Canara Bank, NMDC, Godfrey Phillips: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com advises selling Canara Bank, NMDC and Godfrey Phillips.

  • Buy, Sell, Hold: 7 stocks are on analysts' radar on January 29, 2018

    Maruti, DRL and UPL, among others, are being tracked by investors on Monday.

  • Buy Escorts, Mphasis: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Escorts and Mphasis.

  • Buy Axis Bank, Dr Reddy's Labs, TCS, Wockhardt; exit MMTC: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Axis Bank, Dr Reddy's Labs, TCS and Wockhardt and can exit MMTC.

  • Bull's Eye: Buy Dr Reddy's Lab, Prism Cement, Gati, Just Dial; sell OBC, MGL

    Sameet Chavan of Angel Broking is of the view that one may sell OBC with a target of Rs 110.

  • Don’t ignore out of Out-of-favor stocks; top 10 contrarians buy & sell ideas

    Most of the high beta stocks saw strong momentum in the year 2017 and is finding favour in the year 2018 as well. But, will it work every time? Well, analysts are of the view that out-of-favor stocks have beaten the benchmark in the last 10 years.

  • Top 5 stocks which could turn out to be ‘Dark Horse’ of the year 2018; do you own them?

    Investors are better off betting on stocks which can deliver benchmark beating gains.

  • Buy, Sell, Hold: 2 stocks and 4 sectors on analysts radar on January 4

    Credit Suisse has an Outperform rating for Tata Steel with target price at Rs 830 per share and JSW Steel with target at Rs 300, but has a neutral rating for Jindal Steel & Power with target price at Rs 150.

  • Buy Indo Count Industries, Dr Reddy's Laboratories, Motherson Sumi: Chandan Taparia

    Chandan Taparia of Motilal Oswal Securities is of the view that one may buy Indo Count Industries, Dr Reddy's Laboratories and Motherson Sumi.

  • Buy Escorts, Dr Reddy's Laboratories: Sandeep Wagle

    Sandeep Wagle of powermywealth.com advises buying Escorts and Dr Reddy's Laboratories.

  • Top buy, sell ideas by Mitessh Thakkar, Sandeep Wagle & Ashwani Gujral for December 27

    Ashwani Gujral of ashwanigujral.com is of the view that one may buy PC Jeweller with a target at Rs 458.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347